This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
The inspection conducted from December 16, 2024 to December 20, 2024 by the Brazil Health Regulatory Agency (ANVISA)
he inspection covering the sterile drug product filling and packaging line, quality systems and quality control laboratories concluded compliance with the principles and guidelines of Good Manufacturing Practice
The Subsidiary has received one inspectional observation in Form 483
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
The inspection has concluded with four observations
USFDA inspection at Emcure Pharmaceuticals API facility
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
The Alathur facility specializes in the production of Cephalosporin antibiotics
Subscribe To Our Newsletter & Stay Updated
